• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Anamorelin Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5752693

Description: Anamorelin is a novel ghrelin receptor agonist (EC50: 0.74 nM in the FLIPR assay). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Anamorelin, Inhibitor
Full Product Name
Anamorelin
Product Synonym Names
RC-1291; ONO-7643
Form/Format
Solid
Purity/Purification
99.35%
Preparation and Storage
Store at -20°C.
Molecular Weight
546.7
Molecular Formula
C31H42N6O3
CAS No.
249921-19-5
HPLC
Consistent with structure
HNMR
Consistent with structure
Conclusion
The test result is consistent with structure.
Targets(IC50)
GHSR
In vitro
Anamorelin(ANAM) is a potent and highly specific ghrelin receptor agonist
In vivo
Anamorelin(ANAM) showed significant agonist and binding activity on the ghrelin receptor, and stimulated GH release in vitro. In rats, ANAM significantly and dosedependently increased FI and BW at all dose levels compared with control, and significantly increased GH levels at 10 or 30 mg/kg doses. Increases in GH and IGF-1 levels were observed following ANAM administration in pigs.
Solubility
DMSO: 100 mg/mL (182.92 mM)
(< 1 mg/ml refers to the product slightly soluble or insoluble)

Testing Data (TD) of Anamorelin, inhibitor

Preparing Stock Solutions
Anamorelin Inhibitor, Testing Data (TD) – Cat# MBS5752693

Product References and Citations for Anamorelin, inhibitor

Pietra C, et al. Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment,of cancer anorexia-cachexiasyndrome: preclinical profile. J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):329-37.
Pietra C, et al. Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment,of cancer anorexia-cachexiasyndrome: preclinical profile. J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):329-37.

Other Notes

Small volumes of Anamorelin, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Anamorelin purchase

MBS5752693 is an inhibitor targeting Anamorelin.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000